TY - JOUR
T1 - Acute Ischaemic Stroke Incidence after Coronavirus Vaccine in Indonesia
T2 - Case Series
AU - Hidayat, Rakhmad
AU - Diafiri, Dinda
AU - Zairinal, Ramdinal Aviesena
AU - Arifin, Ghafur Rasyid
AU - Azzahroh, Faiza
AU - Widjaya, Nita
AU - Fani, Devi Nurfadila
AU - Kurniawan, Mohammad
AU - Rasyid, Al
AU - Giantini, Astuti
AU - Haris, Salim
AU - Mesiano, Taufik
N1 - Publisher Copyright:
Copyright© Bentham Science Publishers; For any queries, please email at [email protected].
PY - 2021
Y1 - 2021
N2 - BACKGROUND: Coronavirus disease-19 (COVID-19) is an infectious disease with high morbidity and mortality rates. Indonesia had reported a 2.8% of mortality rate up to June 2021. CASE PRESENTATION: A strategy to control the virus spreading is by vaccination. The Indonesian Food and Drug Monitoring Agency had approved the use of CoronaVac, an inactivated virus vaccine developed by Sinovac. Most Adverse Events Following Immunization (AEFI) for Corona- Vac are mild, and the most common symptoms are injection-site pain, headache, and fatigue. Neurovascular adverse events, including thrombosis or ischaemic stroke after receiving CoronaVac have not previously been reported. CONCLUSION: Correspondingly, we reported three patients with an Acute Ischaemic Stroke (AIS) after the administration of CoronaVac in our hospital.
AB - BACKGROUND: Coronavirus disease-19 (COVID-19) is an infectious disease with high morbidity and mortality rates. Indonesia had reported a 2.8% of mortality rate up to June 2021. CASE PRESENTATION: A strategy to control the virus spreading is by vaccination. The Indonesian Food and Drug Monitoring Agency had approved the use of CoronaVac, an inactivated virus vaccine developed by Sinovac. Most Adverse Events Following Immunization (AEFI) for Corona- Vac are mild, and the most common symptoms are injection-site pain, headache, and fatigue. Neurovascular adverse events, including thrombosis or ischaemic stroke after receiving CoronaVac have not previously been reported. CONCLUSION: Correspondingly, we reported three patients with an Acute Ischaemic Stroke (AIS) after the administration of CoronaVac in our hospital.
KW - AEFI
KW - CoronaVac
KW - COVID 19.
KW - COVID-19
KW - stroke
KW - vaccine
UR - http://www.scopus.com/inward/record.url?scp=85123387853&partnerID=8YFLogxK
U2 - 10.2174/1567202618666210927095613
DO - 10.2174/1567202618666210927095613
M3 - Article
C2 - 34579636
AN - SCOPUS:85123387853
SN - 1567-2026
VL - 18
SP - 360
EP - 363
JO - Current Neurovascular Research
JF - Current Neurovascular Research
IS - 3
ER -
